RIPK1 and Alzheimer disease: Although the pathological mechanism of AD remains unclear, multiple factors, such as genetics, aging, and neuroinflammation, contribute to the occurrence and development of AD.[23, 24] The identification of RIPK1 as a key mediator of both necroptosis and microglial inflammation in AD provides a new strategy for disease diagnosis and treatment.